NO932101L - Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker - Google Patents

Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker

Info

Publication number
NO932101L
NO932101L NO93932101A NO932101A NO932101L NO 932101 L NO932101 L NO 932101L NO 93932101 A NO93932101 A NO 93932101A NO 932101 A NO932101 A NO 932101A NO 932101 L NO932101 L NO 932101L
Authority
NO
Norway
Prior art keywords
humans
administered
substances
polypeptid
material used
Prior art date
Application number
NO93932101A
Other languages
English (en)
Other versions
NO932101D0 (no
NO308396B1 (no
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO932101D0 publication Critical patent/NO932101D0/no
Publication of NO932101L publication Critical patent/NO932101L/no
Publication of NO308396B1 publication Critical patent/NO308396B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932101A 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur NO308396B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy

Publications (3)

Publication Number Publication Date
NO932101D0 NO932101D0 (no) 1993-06-09
NO932101L true NO932101L (no) 1993-08-10
NO308396B1 NO308396B1 (no) 2000-09-11

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932101A NO308396B1 (no) 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Country Status (16)

Country Link
US (1) US5824640A (no)
EP (1) EP0574394B1 (no)
JP (1) JP3213942B2 (no)
KR (1) KR100196028B1 (no)
AT (1) ATE122890T1 (no)
AU (1) AU661287B2 (no)
CA (1) CA2098113C (no)
CZ (1) CZ283037B6 (no)
DE (1) DE69110060T2 (no)
DK (1) DK0574394T3 (no)
ES (1) ES2073277T3 (no)
HU (1) HU217615B (no)
IT (1) IT1244879B (no)
NO (1) NO308396B1 (no)
RU (1) RU2113224C1 (no)
WO (1) WO1992010197A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
DE69719525T2 (de) * 1996-09-18 2003-10-02 Zetesis S.P.A., Mailand/Milano Verwendung von proteine als mittel gegen autoimmunekrankheiten
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
MXPA02012092A (es) * 2000-06-08 2004-08-19 Rakepoll Holding B V Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.
EP1286683A2 (en) * 2000-06-08 2003-03-05 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
WO1985003003A1 (en) * 1984-01-12 1985-07-18 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
EP0574394A1 (en) 1993-12-22
CA2098113C (en) 2002-02-05
IT9022341A1 (it) 1992-06-11
DE69110060T2 (de) 1995-09-28
NO932101D0 (no) 1993-06-09
WO1992010197A1 (en) 1992-06-25
AU661287B2 (en) 1995-07-20
KR100196028B1 (ko) 1999-06-15
ES2073277T3 (es) 1995-08-01
JPH06504039A (ja) 1994-05-12
HU217615B (hu) 2000-03-28
EP0574394B1 (en) 1995-05-24
CZ283037B6 (cs) 1997-12-17
HU9301677D0 (en) 1993-09-28
DK0574394T3 (da) 1995-10-16
RU2113224C1 (ru) 1998-06-20
AU9035791A (en) 1992-07-08
DE69110060D1 (de) 1995-06-29
NO308396B1 (no) 2000-09-11
IT9022341A0 (it) 1990-12-11
CZ111693A3 (en) 1994-04-13
JP3213942B2 (ja) 2001-10-02
HUT64569A (en) 1994-01-28
ATE122890T1 (de) 1995-06-15
CA2098113A1 (en) 1992-06-11
US5824640A (en) 1998-10-20
IT1244879B (it) 1994-09-12

Similar Documents

Publication Publication Date Title
NO932101D0 (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
DK0584266T3 (da) Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
ATE260666T1 (de) Zellulärer impfstoff und deren verwendung für die behandlung von malignen, soliden tumoren
DE69635349D1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
ES2187568T3 (es) Vacuna viva para el tratamiento de enfermedades tumorales.
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
PT951553E (pt) Proteinas de e4 de adenovirus para unducao de morte celular
ATE187493T1 (de) Gp75 als tumorimpfstoff gegen melanome
RU94045930A (ru) Белки, днк, вектор, клетка, способы получения и очистки белка, фармацевтическая композиция
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
EP0136093A3 (en) Anti-cancer factors
DE69803052D1 (de) Therapeutischer viraler wirkstoff, welcher das fortschreiten von tumoren stoppt
DK0455769T3 (da) Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker
ATE65027T1 (de) Behandlung von parasiterkrankungen.
Macher et al. Melanoma: Clinical and Therapeutic Aspects
ATE98262T1 (de) Das lungenwachstum stimulierende und hemmende faktoren fuer krebstumorzellen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees